by John Moore | March 25, 2020
Does a PHM Strategy Give Leg-up During COVID19?
As the #COVID19 pandemic storms across the U.S., a thought I’ve been pondering is: Will there be a measurable difference […]
Tag Archive: vbc
by John Moore | March 25, 2020
As the #COVID19 pandemic storms across the U.S., a thought I’ve been pondering is: Will there be a measurable difference […]
by John Moore | March 02, 2020
The population health management (PHM) journey for provider organizations is not paved in gold, nor silver – it’s actually not […]
by Chilmark Team | February 13, 2020
Once again, the Chilmark team is headed to Orlando for another HIMSS Global Conference and Exhibition. While many focus on […]
by John Moore | January 20, 2020
Last week was the annual pilgrimage to San Francisco to attend the J.P. Morgan (JPM) conference. Actually, I do not […]
by Brian Murphy | November 18, 2019
The organizations responsible for paying for healthcare – health insurance carriers, health plans, employers, and governmental organizations – rely on […]
by Brian Murphy | March 05, 2019
We will release our newest report, 2019 Healthcare Provider Analytics Market Trends Report, in the next few days. This report […]
by Jennifer Rogers | July 25, 2017
Prior Authorization is often viewed as the poster child for throwing the Quadruple Aim off balance with its pursuit of […]
by Jody Ranck | August 20, 2015
The move to Value Based Care (VBC) is changing the relationships that pharma has historically had with both payers and providers. The growing chronic disease burden, rise of digital health and commoditization of many drug-disease areas is forcing a rethinking of the underlying pharmaceutical (pharma) business model.
Chilmark Team · 2 months ago
Hannah Ehnle · 3 weeks ago
Alex Lennox-Miller · 2 months ago